Altathera Pharms Llc Drug Patent Portfolio
Altathera Pharms Llc owns 1 orange book drug protected by 4 US patents Given below is the list of Altathera Pharms Llc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11583216 | Method of administering sotalol IV/switch | 21 Aug, 2039 | Active |
| US10799138 | Method of administering sotalol IV/switch | 05 Apr, 2039 | Active |
| US10512620 | Method of initiating and escalating sotalol hydrochloride dosing | 14 Aug, 2038 | Active |
| US11696902 | Method of initiating and escalating sotalol hydrochloride dosing | 14 Aug, 2038 | Active |
Latest Legal Activities on Altathera Pharms Llc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Altathera Pharms Llc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 15 Apr, 2024 | US10799138 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 26 Dec, 2023 | US11850222 |
|
Email Notification
Critical
| 26 Dec, 2023 | US11850222 |
| Recordation of Patent eGrant | 26 Dec, 2023 | US11850222 |
| Patent eGrant Notification | 26 Dec, 2023 | US11850222 |
| Mail Patent eGrant Notification | 26 Dec, 2023 | US11850222 |
|
Recordation of Patent Grant Mailed
Critical
| 26 Dec, 2023 | US11850222 |
|
Email Notification
Critical
| 07 Dec, 2023 | US11850222 |
|
Issue Notification Mailed
Critical
| 06 Dec, 2023 | US11850222 |
| Dispatch to FDC | 13 Nov, 2023 | US11850222 |
|
Application Is Considered Ready for Issue
Critical
| 13 Nov, 2023 | US11850222 |
|
Issue Fee Payment Verified
Critical
| 06 Nov, 2023 | US11850222 |
|
Issue Fee Payment Received
Critical
| 06 Nov, 2023 | US11850222 |
| Printer Rush- No mailing | 29 Sep, 2023 | US11850222 |
|
Case Docketed to Examiner in GAU
Critical
| 21 Sep, 2023 | US11850222 |
Altathera Pharms Llc's Family Patents
Altathera Pharms Llc Drug List
Given below is the complete list of Altathera Pharms Llc's drugs and the patents protecting them.
1. Sotalol Hydrochloride
Sotalol Hydrochloride is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11583216 | Method of administering sotalol IV/switch |
21 Aug, 2039
(14 years from now)
| Active |
| US10799138 | Method of administering sotalol IV/switch |
05 Apr, 2039
(13 years from now)
| Active |
| US10512620 | Method of initiating and escalating sotalol hydrochloride dosing |
14 Aug, 2038
(13 years from now)
| Active |
| US11696902 | Method of initiating and escalating sotalol hydrochloride dosing |
14 Aug, 2038
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sotalol Hydrochloride's drug page